ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mental Illness Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-6N11546
Home | Market Reports | Health| Mental Health
Global Mental Illness Drugs Market Research Report 2022
BUY CHAPTERS

Global Mental Illness Drugs Market Research Report 2025

Code: QYRE-Auto-6N11546
Report
September 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson and Johnson
Pfizer Inc
Eli Lilly
GlaxoSmithKline PLC
Astrazeneca plc
Bristol–Myers Squibb

Mental Illness Drugs Market Size

The global market for Mental Illness Drugs was valued at US$ 1709 million in the year 2024 and is projected to reach a revised size of US$ 2522 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Mental Illness Drugs Market

Mental Illness Drugs Market

Mental Illness is a psychological anomaly that is reflected in patient’s behavior through disability, distress, or any conduct that is not considered as normal mental development. The causes of mental lllness are very diverse and often unclear in most cases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mental Illness Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mental Illness Drugs.
The Mental Illness Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mental Illness Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mental Illness Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mental Illness Drugs Market Report

Report Metric Details
Report Name Mental Illness Drugs Market
Accounted market size in year US$ 1709 million
Forecasted market size in 2031 US$ 2522 million
CAGR 5.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Antipsychotics
  • Antidepressants
  • Antianxiety (anxiolyitcs)
  • Anti-seizure medications
  • Stimulants
  • Cognitive disorders and dementia
  • Sleep disorder treatments
  • Substance abuse treatments
Segment by Application
  • Hospital
  • Clinic
  • Drugstore
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson and Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mental Illness Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mental Illness Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Mental Illness Drugs Market growing?

Ans: The Mental Illness Drugs Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Mental Illness Drugs Market size in 2031?

Ans: The Mental Illness Drugs Market size in 2031 will be US$ 2522 million.

Who are the main players in the Mental Illness Drugs Market report?

Ans: The main players in the Mental Illness Drugs Market are Johnson and Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb

What are the Application segmentation covered in the Mental Illness Drugs Market report?

Ans: The Applications covered in the Mental Illness Drugs Market report are Hospital, Clinic, Drugstore

What are the Type segmentation covered in the Mental Illness Drugs Market report?

Ans: The Types covered in the Mental Illness Drugs Market report are Antipsychotics, Antidepressants, Antianxiety (anxiolyitcs), Anti-seizure medications, Stimulants, Cognitive disorders and dementia, Sleep disorder treatments, Substance abuse treatments

1 Mental Illness Drugs Market Overview
1.1 Product Definition
1.2 Mental Illness Drugs by Type
1.2.1 Global Mental Illness Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Antipsychotics
1.2.3 Antidepressants
1.2.4 Antianxiety (anxiolyitcs)
1.2.5 Anti-seizure medications
1.2.6 Stimulants
1.2.7 Cognitive disorders and dementia
1.2.8 Sleep disorder treatments
1.2.9 Substance abuse treatments
1.3 Mental Illness Drugs by Application
1.3.1 Global Mental Illness Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstore
1.4 Global Mental Illness Drugs Market Size Estimates and Forecasts
1.4.1 Global Mental Illness Drugs Revenue 2020-2031
1.4.2 Global Mental Illness Drugs Sales 2020-2031
1.4.3 Global Mental Illness Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mental Illness Drugs Market Competition by Manufacturers
2.1 Global Mental Illness Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mental Illness Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mental Illness Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mental Illness Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mental Illness Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mental Illness Drugs, Product Type & Application
2.7 Global Key Manufacturers of Mental Illness Drugs, Date of Enter into This Industry
2.8 Global Mental Illness Drugs Market Competitive Situation and Trends
2.8.1 Global Mental Illness Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mental Illness Drugs Players Market Share by Revenue
2.8.3 Global Mental Illness Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mental Illness Drugs Market Scenario by Region
3.1 Global Mental Illness Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mental Illness Drugs Sales by Region: 2020-2031
3.2.1 Global Mental Illness Drugs Sales by Region: 2020-2025
3.2.2 Global Mental Illness Drugs Sales by Region: 2026-2031
3.3 Global Mental Illness Drugs Revenue by Region: 2020-2031
3.3.1 Global Mental Illness Drugs Revenue by Region: 2020-2025
3.3.2 Global Mental Illness Drugs Revenue by Region: 2026-2031
3.4 North America Mental Illness Drugs Market Facts & Figures by Country
3.4.1 North America Mental Illness Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mental Illness Drugs Sales by Country (2020-2031)
3.4.3 North America Mental Illness Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mental Illness Drugs Market Facts & Figures by Country
3.5.1 Europe Mental Illness Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mental Illness Drugs Sales by Country (2020-2031)
3.5.3 Europe Mental Illness Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mental Illness Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Mental Illness Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mental Illness Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Mental Illness Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mental Illness Drugs Market Facts & Figures by Country
3.7.1 Latin America Mental Illness Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mental Illness Drugs Sales by Country (2020-2031)
3.7.3 Latin America Mental Illness Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mental Illness Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Mental Illness Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mental Illness Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mental Illness Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Mental Illness Drugs Sales by Type (2020-2031)
4.1.1 Global Mental Illness Drugs Sales by Type (2020-2025)
4.1.2 Global Mental Illness Drugs Sales by Type (2026-2031)
4.1.3 Global Mental Illness Drugs Sales Market Share by Type (2020-2031)
4.2 Global Mental Illness Drugs Revenue by Type (2020-2031)
4.2.1 Global Mental Illness Drugs Revenue by Type (2020-2025)
4.2.2 Global Mental Illness Drugs Revenue by Type (2026-2031)
4.2.3 Global Mental Illness Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Mental Illness Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mental Illness Drugs Sales by Application (2020-2031)
5.1.1 Global Mental Illness Drugs Sales by Application (2020-2025)
5.1.2 Global Mental Illness Drugs Sales by Application (2026-2031)
5.1.3 Global Mental Illness Drugs Sales Market Share by Application (2020-2031)
5.2 Global Mental Illness Drugs Revenue by Application (2020-2031)
5.2.1 Global Mental Illness Drugs Revenue by Application (2020-2025)
5.2.2 Global Mental Illness Drugs Revenue by Application (2026-2031)
5.2.3 Global Mental Illness Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Mental Illness Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson and Johnson
6.1.1 Johnson and Johnson Company Information
6.1.2 Johnson and Johnson Description and Business Overview
6.1.3 Johnson and Johnson Mental Illness Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson and Johnson Mental Illness Drugs Product Portfolio
6.1.5 Johnson and Johnson Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Mental Illness Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Mental Illness Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Mental Illness Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly Mental Illness Drugs Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Company Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Mental Illness Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GlaxoSmithKline Mental Illness Drugs Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Mental Illness Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AstraZeneca Mental Illness Drugs Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Company Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Mental Illness Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bristol-Myers Squibb Mental Illness Drugs Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mental Illness Drugs Industry Chain Analysis
7.2 Mental Illness Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mental Illness Drugs Production Mode & Process Analysis
7.4 Mental Illness Drugs Sales and Marketing
7.4.1 Mental Illness Drugs Sales Channels
7.4.2 Mental Illness Drugs Distributors
7.5 Mental Illness Drugs Customer Analysis
8 Mental Illness Drugs Market Dynamics
8.1 Mental Illness Drugs Industry Trends
8.2 Mental Illness Drugs Market Drivers
8.3 Mental Illness Drugs Market Challenges
8.4 Mental Illness Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Johnson and Johnson
Pfizer Inc
Eli Lilly
GlaxoSmithKline PLC
Astrazeneca plc
Bristol–Myers Squibb
List of Tables
 Table 1. Global Mental Illness Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Mental Illness Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Mental Illness Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Mental Illness Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Mental Illness Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Mental Illness Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Mental Illness Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Mental Illness Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Mental Illness Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mental Illness Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mental Illness Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Mental Illness Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mental Illness Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Illness Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mental Illness Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Mental Illness Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Mental Illness Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Mental Illness Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Mental Illness Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Mental Illness Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Mental Illness Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Mental Illness Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Mental Illness Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Mental Illness Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Mental Illness Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Mental Illness Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Mental Illness Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Mental Illness Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Mental Illness Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Mental Illness Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Mental Illness Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Mental Illness Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Mental Illness Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Mental Illness Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Mental Illness Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Mental Illness Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Mental Illness Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Mental Illness Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Mental Illness Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Mental Illness Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Mental Illness Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Mental Illness Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Mental Illness Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Mental Illness Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Mental Illness Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Mental Illness Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Mental Illness Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Mental Illness Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Mental Illness Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Mental Illness Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Mental Illness Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Mental Illness Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Mental Illness Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Mental Illness Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Mental Illness Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Mental Illness Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Mental Illness Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Mental Illness Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Mental Illness Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Mental Illness Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Mental Illness Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Mental Illness Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Mental Illness Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Mental Illness Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Mental Illness Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Mental Illness Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Mental Illness Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Mental Illness Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. Johnson and Johnson Company Information
 Table 71. Johnson and Johnson Description and Business Overview
 Table 72. Johnson and Johnson Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Johnson and Johnson Mental Illness Drugs Product
 Table 74. Johnson and Johnson Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Mental Illness Drugs Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Eli Lilly Company Information
 Table 81. Eli Lilly Description and Business Overview
 Table 82. Eli Lilly Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Eli Lilly Mental Illness Drugs Product
 Table 84. Eli Lilly Recent Developments/Updates
 Table 85. GlaxoSmithKline Company Information
 Table 86. GlaxoSmithKline Description and Business Overview
 Table 87. GlaxoSmithKline Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. GlaxoSmithKline Mental Illness Drugs Product
 Table 89. GlaxoSmithKline Recent Developments/Updates
 Table 90. AstraZeneca Company Information
 Table 91. AstraZeneca Description and Business Overview
 Table 92. AstraZeneca Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. AstraZeneca Mental Illness Drugs Product
 Table 94. AstraZeneca Recent Developments/Updates
 Table 95. Bristol-Myers Squibb Company Information
 Table 96. Bristol-Myers Squibb Description and Business Overview
 Table 97. Bristol-Myers Squibb Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Bristol-Myers Squibb Mental Illness Drugs Product
 Table 99. Bristol-Myers Squibb Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Mental Illness Drugs Distributors List
 Table 103. Mental Illness Drugs Customers List
 Table 104. Mental Illness Drugs Market Trends
 Table 105. Mental Illness Drugs Market Drivers
 Table 106. Mental Illness Drugs Market Challenges
 Table 107. Mental Illness Drugs Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mental Illness Drugs
 Figure 2. Global Mental Illness Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Mental Illness Drugs Market Share by Type: 2024 & 2031
 Figure 4. Antipsychotics Product Picture
 Figure 5. Antidepressants Product Picture
 Figure 6. Antianxiety (anxiolyitcs) Product Picture
 Figure 7. Anti-seizure medications Product Picture
 Figure 8. Stimulants Product Picture
 Figure 9. Cognitive disorders and dementia Product Picture
 Figure 10. Sleep disorder treatments Product Picture
 Figure 11. Substance abuse treatments Product Picture
 Figure 12. Global Mental Illness Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 13. Global Mental Illness Drugs Market Share by Application: 2024 & 2031
 Figure 14. Hospital
 Figure 15. Clinic
 Figure 16. Drugstore
 Figure 17. Global Mental Illness Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Mental Illness Drugs Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Mental Illness Drugs Sales (2020-2031) & (K Units)
 Figure 20. Global Mental Illness Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 21. Mental Illness Drugs Report Years Considered
 Figure 22. Mental Illness Drugs Sales Share by Manufacturers in 2024
 Figure 23. Global Mental Illness Drugs Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Mental Illness Drugs Players: Market Share by Revenue in Mental Illness Drugs in 2024
 Figure 25. Mental Illness Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Mental Illness Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Mental Illness Drugs Sales Market Share by Country (2020-2031)
 Figure 28. North America Mental Illness Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Mental Illness Drugs Sales Market Share by Country (2020-2031)
 Figure 32. Europe Mental Illness Drugs Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Mental Illness Drugs Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Mental Illness Drugs Revenue Market Share by Region (2020-2031)
 Figure 40. China Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Mental Illness Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Mental Illness Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Mental Illness Drugs Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Mental Illness Drugs Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. U.A.E Mental Illness Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Mental Illness Drugs by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Mental Illness Drugs by Type (2020-2031)
 Figure 62. Global Mental Illness Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Mental Illness Drugs by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Mental Illness Drugs by Application (2020-2031)
 Figure 65. Global Mental Illness Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 66. Mental Illness Drugs Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Mental Health Counseling Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-36R16857
Tue Nov 11 00:00:00 UTC 2025

Add to Cart

Global Psychiatric Rehabilitation Digital Therapy Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-29H16590
Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Global Psychological Healing Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-6J17514
Wed Nov 05 00:00:00 UTC 2025

Add to Cart

Global Neuropsychological Assessment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-31Q17066
Wed Nov 05 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions